BUCK INSTITUTE FOR RESEARCH ON AGING

Clinical Trials
5
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Temporal Investigation of Multimodal Elements
- Conditions
- Health
- First Posted Date
- 2025-08-06
- Last Posted Date
- 2025-08-15
- Lead Sponsor
- Buck Institute for Research on Aging
- Target Recruit Count
- 120
- Registration Number
- NCT07107386
- Locations
- 🇺🇸
Buck Institute, Novato, California, United States
GLYLO Supplement Pilot Trial on Glycation and Aging in Postmenopausal Women
- Conditions
- PostmenopauseMetabolismGeroscience
- First Posted Date
- 2025-02-06
- Last Posted Date
- 2025-07-18
- Lead Sponsor
- Buck Institute for Research on Aging
- Target Recruit Count
- 30
- Registration Number
- NCT06813261
- Locations
- 🇺🇸
The Buck Institute for Research on Aging, Novato, California, United States
Targeting Aging With a Ketone Ester for Function in Frailty
- Conditions
- Frail ElderlyAgingImmune FunctionMuscle Function
- First Posted Date
- 2024-10-17
- Last Posted Date
- 2025-08-15
- Lead Sponsor
- Buck Institute for Research on Aging
- Target Recruit Count
- 180
- Registration Number
- NCT06645847
- Locations
- 🇺🇸
Buck Institute for Research on Aging, Novato, California, United States
🇺🇸UConn Health, Farmington, Connecticut, United States
🇺🇸Ohio State University, Columbus, Ohio, United States
Molecular Optimization Via Exercise (MOVE)
- Conditions
- Aging
- First Posted Date
- 2024-08-06
- Last Posted Date
- 2024-10-08
- Lead Sponsor
- Buck Institute for Research on Aging
- Target Recruit Count
- 80
- Registration Number
- NCT06540287
- Locations
- 🇺🇸
Buck Institute for Research on Aging, Novato, California, United States
Buck Institute Ketone Ester RCT
- Conditions
- Safety IssuesToleranceAging
- First Posted Date
- 2022-10-19
- Last Posted Date
- 2024-06-11
- Lead Sponsor
- Buck Institute for Research on Aging
- Target Recruit Count
- 30
- Registration Number
- NCT05585762
- Locations
- 🇺🇸
Buck Institute for Research on Aging, Novato, California, United States
News
Therapeutic Plasma Exchange Combined with Immunoglobulin Reduces Biological Age by 2.6 Years in Clinical Trial
A first-of-its-kind clinical trial demonstrates that therapeutic plasma exchange combined with intravenous immunoglobulin reduced biological age by an average of 2.61 years as measured by multi-omic biomarkers.
Metformin's Potential in Slowing Aging to be Examined in TAME Trial
The TAME Trial will investigate metformin's potential to prevent age-related diseases like heart disease, cancer, and cognitive decline in healthy older adults.